Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-25-020121
Filing Date
2025-07-22
Accepted
2025-07-22 16:20:31
Documents
2
Period of Report
2025-07-18

Document Format Files

Seq Description Document Type Size
1 form3-07222025_080727.html 3  
1 form3-07222025_080727.xml 3 1741
2 ex24-07222025_080727.htm EX-24 3822
  Complete submission text file 0001415889-25-020121.txt   6974
Mailing Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730
Business Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730 909-980-9484
Amphastar Pharmaceuticals, Inc. (Issuer) CIK: 0001297184 (see all company filings)

EIN.: 330702205 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O AMPHASTAR PHARMACEUTICALS, INC. 11570 6TH STREET RANCHO CUCAMONGA CA 91730
Business Address
Gaugh David Russell (Reporting) CIK: 0002075974 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36509 | Film No.: 251140536